Our CEO, Monika Paule, is featured in Citeline Commercial’s Scrip Asks series “What Does 2025 Hold For Biopharma?”, where she shares her insights on the biopharma industry in 2025.
In this latest article, Monika emphasizes the critical role of collaboration in transforming novel technologies into advanced therapies and ensuring their accessibility to patients.
Explore the full feature to gain further insights from industry leaders and experts.